欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/2026/002
药品名称
Candesartan 8 mg
活性成分
candesartancilexetil 8.0 mg
剂型
Tablet
上市许可持有人
Teva Nederland B.V., Swensweg 5, 2031 GA Haarlem, The Netherlands
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
许可日期
2010/06/25
最近更新日期
2020/01/28
药物ATC编码
C09CA06 candesartan
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
1.3.1 spc-eu clean2_OK
Date of last change:2018/06/26
Final PL
|
1.3.1 pil-eu clean
Date of last change:2018/06/26
Final Labelling
|
1.3.1 label outer -eu-clean
Date of last change:2018/03/29
PAR
|
PAR_2026_DC_candesartan_21 okt 2010
Date of last change:2014/03/05
Final Product Information
|
common-outer-clean
Date of last change:2013/09/17
Final Product Information
|
common-pl-candesartanclean
Date of last change:2013/09/17
Final Product Information
|
common-spc-candesartanclean
Date of last change:2013/09/17
市场状态
Withdrawn(注:已撤市)
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase